StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Veracyte, Inc.
NasdaqGM:VCYT
Sector
Location
Market Cap
USD 1.84 B
Share Price
USD 23.51
Avg Daily Volume
1,028,606
Change (1 day)
2.08%
Change (1 year)
0.17%
Change (YTD)
-40.63%
Veracyte, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2025: USD 26.86 M
Veracyte, Inc. EBIT is USD 26.86 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -137.57% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
-
Veracyte, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -71.50 M, a 132.51% change year over year.
-
Veracyte, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -30.75 M, a -38.63% change year over year.
-
Veracyte, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -50.11 M, a -26.81% change year over year.
-
Veracyte, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -68.47 M, a 212.56% change year over year.
Competitors
Natera, Inc.
USD 139.92
NTRA
-0.71
-0.51%
Tempus AI, Inc.
USD 61.08
TEM
+3.07
5.29%
Roche Holding AG
USD 337.58
RO.SW
-0.59
-0.18%
Abbott Laboratories
USD 125.73
ABT
+1.31
1.05%
Boston Scientific Corporation
USD 103.16
BSX
-0.62
-0.60%
Thermo Fisher Scientific Inc.
USD 427.62
TMO
+22.68
5.60%
Medtronic plc
USD 91.65
MDT
+1.95
2.17%
RELX Plc
USD 52.48
REL.L
-0.41
-0.77%
Siemens Healthineers AG
USD 53.69
SHL.DE
+0.16
0.29%
Becton, Dickinson and Company
USD 181.28
BDX
+5.95
3.39%
Edwards Lifesciences Corporation
USD 76.30
EW
-0.26
-0.34%
IDEXX Laboratories, Inc.
USD 532.00
IDXX
+11.13
2.14%
GE HealthCare Technologies Inc.
USD 76.49
GEHC
+2.33
3.14%
DexCom, Inc.
USD 85.12
DXCM
+1.09
1.30%
Agilent Technologies, Inc.
USD 116.19
A
+4.15
3.70%
Laboratory Corporation of America Holdings
USD 252.07
LH
+9.03
3.72%
Waters Corporation
USD 287.46
WAT
+5.80
2.06%
bioMérieux S.A.
USD 139.99
BIM.PA
+1.59
1.15%
West Pharmaceutical Services, Inc.
USD 218.90
WST
+8.82
4.20%
Illumina, Inc.
USD 102.03
ILMN
+7.23
7.63%
Key Data
| Date | EBIT | EBITDA | Net Income | EPS (Diluted) |
|---|
Competitors
Natera, Inc.
USD 139.92
NTRA
-0.71
-0.51%
Tempus AI, Inc.
USD 61.08
TEM
+3.07
5.29%
Roche Holding AG
USD 337.58
RO.SW
-0.59
-0.18%
Abbott Laboratories
USD 125.73
ABT
+1.31
1.05%
Boston Scientific Corporation
USD 103.16
BSX
-0.62
-0.60%
Thermo Fisher Scientific Inc.
USD 427.62
TMO
+22.68
5.60%
Medtronic plc
USD 91.65
MDT
+1.95
2.17%
RELX Plc
USD 52.48
REL.L
-0.41
-0.77%
Siemens Healthineers AG
USD 53.69
SHL.DE
+0.16
0.29%
Becton, Dickinson and Company
USD 181.28
BDX
+5.95
3.39%
Edwards Lifesciences Corporation
USD 76.30
EW
-0.26
-0.34%
IDEXX Laboratories, Inc.
USD 532.00
IDXX
+11.13
2.14%
GE HealthCare Technologies Inc.
USD 76.49
GEHC
+2.33
3.14%
DexCom, Inc.
USD 85.12
DXCM
+1.09
1.30%
Agilent Technologies, Inc.
USD 116.19
A
+4.15
3.70%
Laboratory Corporation of America Holdings
USD 252.07
LH
+9.03
3.72%
Waters Corporation
USD 287.46
WAT
+5.80
2.06%
bioMérieux S.A.
USD 139.99
BIM.PA
+1.59
1.15%
West Pharmaceutical Services, Inc.
USD 218.90
WST
+8.82
4.20%
Illumina, Inc.
USD 102.03
ILMN
+7.23
7.63%